162 related articles for article (PubMed ID: 20142990)
1. Long term immunologic consequences of experimental stroke and mucosal tolerance.
Gee JM; Zierath D; Hadwin J; Savos A; Kalil A; Thullbery M; Becker KJ
Exp Transl Stroke Med; 2009 Oct; 1():3. PubMed ID: 20142990
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
Gee JM; Kalil A; Thullbery M; Becker KJ
Stroke; 2008 May; 39(5):1575-82. PubMed ID: 18323496
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
[TBL] [Abstract][Full Text] [Related]
4. Chemical Sympathectomy, but not Adrenergic Blockade, Improves Stroke Outcome.
Zierath D; Olmstead T; Stults A; Shen A; Kunze A; Becker KJ
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3177-3186. PubMed ID: 30120036
[TBL] [Abstract][Full Text] [Related]
5. CNS immune responses following experimental stroke.
Zierath D; Thullbery M; Hadwin J; Gee JM; Savos A; Kalil A; Becker KJ
Neurocrit Care; 2010 Apr; 12(2):274-84. PubMed ID: 19714497
[TBL] [Abstract][Full Text] [Related]
6. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
Khoury SJ; Hancock WW; Weiner HL
J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
[TBL] [Abstract][Full Text] [Related]
7. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.
Becker KJ; McCarron RM; Ruetzler C; Laban O; Sternberg E; Flanders KC; Hallenbeck JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10873-8. PubMed ID: 9380727
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
10. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
[TBL] [Abstract][Full Text] [Related]
12. Mucosal tolerance to brain antigens preserves endogenous TGFβ-1 and improves neurological outcomes following experimental craniotomy.
Jafarian N; Ayer R; Eckermann J; Tong W; Jafarian N; Applegate RL; Stier G; Martin R; Tang J; Zhang JH
Acta Neurochir Suppl; 2011; 111():283-7. PubMed ID: 21725769
[TBL] [Abstract][Full Text] [Related]
13. Promiscuity of autoimmune responses to MBP after stroke.
Zierath D; Kunze A; Fecteau L; Becker K
J Neuroimmunol; 2015 Aug; 285():101-5. PubMed ID: 26198925
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.
Takeda H; Spatz M; Ruetzler C; McCarron R; Becker K; Hallenbeck J
Stroke; 2002 Sep; 33(9):2156-63. PubMed ID: 12215580
[TBL] [Abstract][Full Text] [Related]
15. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.
Becker KJ; Kindrick DL; Lester MP; Shea C; Ye ZC
J Cereb Blood Flow Metab; 2005 Dec; 25(12):1634-44. PubMed ID: 15931160
[TBL] [Abstract][Full Text] [Related]
18. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury.
Chen Y; Ruetzler C; Pandipati S; Spatz M; McCarron RM; Becker K; Hallenbeck JM
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15107-12. PubMed ID: 14645708
[TBL] [Abstract][Full Text] [Related]
19. Antigen-driven bystander suppression after oral administration of antigens.
Miller A; Lider O; Weiner HL
J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
[TBL] [Abstract][Full Text] [Related]
20. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
